
Loading, please wait...

Loading, please wait...

Maverick Simulation Solutions recently introduced SIDDH, an advanced critical care simulator developed and manufactured entirely in India. Consequently, this innovation aims to bridge the gap in hands-on clinical training across Indian medical colleges and hospitals. Furthermore, the 65-kg full-body model replicates real-world medical scenarios with high physiological accuracy. Therefore, it provides a safe environment for healthcare professionals to refine their life-saving skills.
The SIDDH platform integrates advanced lung simulation technology and real-time response systems. Specifically, it allows doctors and nurses to practice complex procedures without risk to live patients. Because the simulator mimics dynamic lung mechanics, learners receive immediate feedback during interventions. Additionally, the system generates real-time arterial blood gas data. Thus, trainees can observe the direct impact of their clinical decisions on patient stability.
One standout feature is the AI-powered ultrasound module. This module includes over 1,000 clinical cases to help practitioners master diagnostic imaging. Moreover, the simulator supports training for cardiac emergencies, respiratory distress, and trauma management. Since the response engine adapts to ventilator adjustments and fluid resuscitation, the training remains highly realistic. Consequently, the technology matches global standards while remaining affordable for local institutions.
Traditionally, Indian medical colleges relied on expensive imported simulators for training. However, Maverick Simulation Solutions aims to change this through domestic manufacturing. By investing in research and AI integration, the company strengthens India's self-reliance in healthcare infrastructure. Several premier institutions have already installed SIDDH, including various campuses of the All India Institute of Medical Sciences. This move aligns with the broader digital transformation of Indian medical education.
Q1: What is SIDDH?
SIDDH is a high-fidelity, Indian-made adult patient simulator designed for critical care training and emergency medical education.
Q2: Who can benefit from using this simulator?
Doctors, nurses, paramedics, and medical students can use the platform to practice complex procedures and manage critical healthcare scenarios safely.
Q3: Does the simulator include diagnostic training tools?
Yes, it features an AI-powered ultrasound module with over 1,000 clinical cases and adaptive guidance for learners.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Maverick Simulation Solutions launched SIDDH, an Indian-made critical care simulator with AI ultrasound and lung simulation to improve clinical training....
8 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Recent clinical studies reveal maternal autoantibodies targeting IL-1RA as potential triggers for preterm labor, opening avenues for targeted cytokine therapies. Concurrently, new perioperative findings show inhaled cannabis increases propofol requirements during upper endoscopy compared to oral edible consumption.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today